Downregulation of stathmin 1 in human gallbladder carcinoma inhibits tumor growth in vitro and in vivo
出版年份 2016 全文链接
标题
Downregulation of stathmin 1 in human gallbladder carcinoma inhibits tumor growth in vitro and in vivo
作者
关键词
-
出版物
Scientific Reports
Volume 6, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-06-28
DOI
10.1038/srep28833
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Enhancement of Chemosensitivity by Stathmin-1 Silencing in Gastric Cancer Cells In Situ and In Vivo
- (2016) Zhi-jian Meng et al. ONCOLOGY RESEARCH
- Molecular genetics and targeted therapeutics in biliary tract carcinoma
- (2016) Eric I Marks WORLD JOURNAL OF GASTROENTEROLOGY
- Pathology of Gallbladder Carcinoma: Current Understanding and New Perspectives
- (2015) Munita Meenu Bal et al. PATHOLOGY & ONCOLOGY RESEARCH
- Gallbladder Cancer in the 21st Century
- (2015) Rani Kanthan et al. Journal of Oncology
- siRNA targeting stathmin inhibits invasion and enhances chemotherapy sensitivity of stem cells derived from glioma cell lines
- (2014) Yuwen Song et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Lentiviral-mediated RNA interference targeting stathmin1 gene in human gastric cancer cells inhibits proliferation in vitro and tumor growth in vivo
- (2013) Javed Akhtar et al. Journal of Translational Medicine
- The microtubule cytoskeleton is required for a G2 cell cycle delay in cancer cells lacking stathmin and p53
- (2012) Bruce K. Carney et al. Cytoskeleton
- Outcomes and prognostic factors in gallbladder cancer: a single-centre experience
- (2012) Katharina Cziupka et al. LANGENBECKS ARCHIVES OF SURGERY
- Stathmin: a protein with many tasks. New biomarker and potential target in cancer
- (2011) Barbara Belletti et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Downregulation of stathmin is involved in malignant phenotype reversion and cell apoptosis in esophageal squamous cell carcinoma
- (2011) Feng Wang et al. JOURNAL OF SURGICAL ONCOLOGY
- Stathmin/oncoprotein 18, a microtubule regulatory protein, is required for survival of both normal and cancer cell lines lacking the tumor suppressor, p53
- (2010) Bruce K. Carney et al. CANCER BIOLOGY & THERAPY
- Stathmin, a New Target of PRL-3 Identified by Proteomic Methods, Plays a Key Role in Progression and Metastasis of Colorectal Cancer
- (2010) Ping Zheng et al. JOURNAL OF PROTEOME RESEARCH
- Gallbladder Cancer: Differences in Presentation, Surgical Treatment, and Survival in Patients Treated at Centers in Three Countries
- (2010) Jean M. Butte et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Stathmin 1: a novel therapeutic target for anticancer activity
- (2008) Shushan Rana et al. Expert Review of Anticancer Therapy
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started